Brian Linscott - 19 Jan 2022 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: HHS
Reported as of: 19 Jan 2022
Net transaction value: +$70,922
SEC form: 4
Accepted by SEC: 20 Jan 2022, 18:32:04 UTC
Prior SEC filing: 03 Dec 2021
Next SEC filing: 28 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Laurilee Kearnes, Attorney-in-Fact for Brian Linscott

Filing notes and source

Key filing fact

Brian Linscott filed Form 4 for HARTE HANKS INC (HHS) on 20 Jan 2022.

Key facts

This page summarizes Brian Linscott's Form 4 filing for HARTE HANKS INC (HHS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Jan 2022, 18:32.

Change

Previous filing in this sequence was filed on 03 Dec 2021.
Current net transaction value: +$70,922.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HHS transaction

Common Stock

Award

Transaction value: $70,922
Shares: +9,623
Change %: +3.2%
Price: $7.37
Shares after: 308,202
Date: 19 Jan 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On January 19, 2022, the reporting individual received 9,623 restricted stock unit (RSU) shares (18,745 RSU shares less 9,122 shares to cover tax withholdings) valued at $7.37 as part of his 2021 bonus package, paid in Q1 2022.